Algorithm for a short course of finasteride in patients with benign prostatic hyperplasia before transurethral resection of the prostate

Benign prostatic hyperplasia (BPH), for a long time known as benign prostatic hypertrophy, is so widespread that many researchers say, it inevitably occurs in men who have lived long enough for BPH to develop. BPH is one of the most common diseases in males from the age of 40-50 years. Histological study reveals hyperplasia in more than 60% of 60-year-old patients, and it is clinically manifested in more than 40% of men of this age group [1]. About 20% of men after the age of 60 note a significant deterioration in the quality of life due to urination disorder. Benign prostatic hyperplasia is characterized by a broad variety of symptoms.